BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23301224)

  • 1. Identification of two novel NPM1 mutations in patients with acute myeloid leukemia.
    Jeon Y; Seo SW; Park S; Park S; Kim SY; Ra EK; Park SS; Seong MW
    Ann Lab Med; 2013 Jan; 33(1):60-4. PubMed ID: 23301224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Novel Mutations of the NPM1 Gene in Syrian Adult Patients with Acute Myeloid Leukemia and Normal Karyotype.
    Alarbeed IF; Wafa A; Moassass F; Al-Halabi B; Alachkar W; Aboukhamis I
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):227-232. PubMed ID: 33507703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of NPM1 gene mutations in acute myeloid leukemia].
    Dai D; Zhang SJ; Qiao C; Sun XM; Qian SX; Xu W; Xu YL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):294-7. PubMed ID: 19379554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPM1 gene mutation in Egyptian patients with cytogenetically normal acute myeloid leukemia.
    Sofan MA; Elmasry S; Salem DA; Bazid MM
    Clin Lab; 2014; 60(11):1813-22. PubMed ID: 25648021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations of the nucleophosmin (NPM-1) gene in Egyptian patients with acute myeloid leukemia: a pilot study.
    Kassem N; Hamid AA; Attia T; Baathallah S; Mahmoud S; Moemen E; Safwat E; Khalaf M; Shaker O
    J Egypt Natl Canc Inst; 2011 Jun; 23(2):73-8. PubMed ID: 22099964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia.
    Mat Yusoff Y; Abu Seman Z; Othman N; Kamaluddin NR; Esa E; Zulkiply NA; Abdullah J; Zakaria Z
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1749-1755. PubMed ID: 31244296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.
    Du Pisani LA; Shires K
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):106-14. PubMed ID: 26183674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.
    Rezaei N; Arandi N; Valibeigi B; Haghpanah S; Khansalar M; Ramzi M
    Turk J Haematol; 2017 Dec; 34(4):300-306. PubMed ID: 28294102
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
    Turk J Haematol; 2018 Mar; 35(1):49-53. PubMed ID: 29129825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of NPM1 gene mutations in acute myeloid leukemia].
    Yan LZ; Chen SN; Liang JY; Feng YF; Cen JN; He J; Chang WR; Zhu ZL; Pan JL; Wu YF; Xue YQ; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):289-93. PubMed ID: 17877154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).
    Thiede C; Koch S; Creutzig E; Steudel C; Illmer T; Schaich M; Ehninger G
    Blood; 2006 May; 107(10):4011-20. PubMed ID: 16455956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
    Martelli MP; Rossi R; Venanzi A; Meggendorfer M; Perriello VM; Martino G; Spinelli O; Ciurnelli R; Varasano E; Brunetti L; Ascani S; Quadalti C; Cardinali V; Mezzasoma F; Gionfriddo I; Milano F; Pacini R; Tabarrini A; Bigerna B; Albano F; Specchia G; Vetro C; Di Raimondo F; Annibali O; Avvisati G; Rambaldi A; Falzetti F; Tiacci E; Sportoletti P; Haferlach T; Haferlach C; Falini B
    Blood; 2021 Dec; 138(25):2696-2701. PubMed ID: 34343258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NPM1 and CEBPA mutations in pediatric cytogenetically normal acute myeloid leukemia].
    Ruan M; Zhang L; Han C; Liu X; Ai X; Zhang J; Liu T; Yang W; Chen X; Guo Y; Wang S; Li Q; Zou Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):303-7. PubMed ID: 24915920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
    Becker H; Marcucci G; Maharry K; Radmacher MD; Mrózek K; Margeson D; Whitman SP; Wu YZ; Schwind S; Paschka P; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Caligiuri MA; Larson RA; Bloomfield CD
    J Clin Oncol; 2010 Feb; 28(4):596-604. PubMed ID: 20026798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations.
    Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
    Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):82-89. PubMed ID: 29079128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML.
    Hollink IH; Zwaan CM; Zimmermann M; Arentsen-Peters TC; Pieters R; Cloos J; Kaspers GJ; de Graaf SS; Harbott J; Creutzig U; Reinhardt D; van den Heuvel-Eibrink MM; Thiede C
    Leukemia; 2009 Feb; 23(2):262-70. PubMed ID: 19020547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleophosmin gene mutations in acute myeloid leukemia.
    Chen W; Rassidakis GZ; Medeiros LJ
    Arch Pathol Lab Med; 2006 Nov; 130(11):1687-92. PubMed ID: 17076533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of acute myeloid leukemia by the revised fourth edition World Health Organization criteria: a retrospective single-institution study with appraisal of the new entities of acute myeloid leukemia with gene mutations in NPM1 and biallelic CEBPA.
    Kansal R
    Hum Pathol; 2019 Aug; 90():80-96. PubMed ID: 31077683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal heterogeneity in patients with cytogenetically normal acute myeloid leukemia with NPM1 mutations.
    Dvorakova D; Racil Z; Borsky M; Robesova B; Jeziskova I; Razga F; Lengerova M; Mayer J
    Leuk Lymphoma; 2013 May; 54(5):1056-60. PubMed ID: 23020761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features.
    Andersen MT; Andersen MK; Christiansen DH; Pedersen-Bjergaard J
    Leukemia; 2008 May; 22(5):951-5. PubMed ID: 18273044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.